Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06370442
PHASE3
Intranasal Dexmedetomidine vs. Standard of Care for Emergency Department (ED) Procedural Sedation in the Older Adult
Sponsor: State University of New York - Upstate Medical University
View on ClinicalTrials.gov
Summary
The purpose of the study is to determine if intranasal dexmedetomidine could be an alternative to the current standard of care (injectable benzodiazepines or antipsychotics) for sedation prior to computerized tomography (CT) or magnetic resonance imaging (MRI) in those greater than or equal to 65 years of age (older adults) that are seen in the Emergency Department (ED).
Key Details
Gender
All
Age Range
65 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-06-01
Completion Date
2025-09-01
Last Updated
2024-04-22
Healthy Volunteers
No
Conditions
Interventions
DRUG
Dexmedetomidine
Intranasal dexmedetomidine, 100mcg
DRUG
Lorazepam
0.5mg IV
DRUG
Haloperidol
0.5mg IV